About: Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2006 (uk) article scientifique publié en 2006 (fr) im Januar 2006 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57222137-8B7826D4-CAFF-44C3-B88C-B6D235C7DB70
publication date	2006-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57222137-10C58E08-C25E-44DB-83CB-D195D3291CCD
language of work or name	English
exact match	wds:Q57222137-83C8B2D9-361B-4C2D-8B1B-AD4ECBE3A5FD
exact match	https://scigraph.springernature.com/pub.10.2165/00002512-200623070-00003
cites work	wds:Q57222137-12A7702A-C0A5-46C3-9969-ECD1E92D83E4 wds:Q57222137-16A46CD8-7698-4637-8D92-E6A2791A4224 wds:Q57222137-1CF771F7-B360-4C45-9C5C-B4283E63095D wds:Q57222137-23D0FBAB-AFDB-46EF-B682-138AEA65409A wds:Q57222137-27A81B15-4436-4393-AA01-4222514CDC62 wds:Q57222137-2A556221-203E-4FF6-B4F5-E76243CCA393 wds:Q57222137-2B2D5AF5-015D-4F04-8E14-8B16BED43131 wds:Q57222137-2D09377E-C9A5-48A5-A12F-4820B85AD07E wds:Q57222137-2D77F528-FDC6-4D16-8B49-0156BA7F1007 wds:Q57222137-2D9EECCB-5167-4681-A9AD-4FDE08E08568 wds:Q57222137-2E7D1C36-4A82-474D-AC5F-32DF95B5E44F wds:Q57222137-328A5789-8751-44F7-8747-51B28D2EF374 wds:Q57222137-38875A94-522D-4C10-A1C5-41F99AA68AAF wds:Q57222137-3C41A1FF-CD26-4880-B475-EE61C9D05322 wds:Q57222137-5AA1DE3E-07D1-4146-8E91-B1FC59DD08E3 wds:Q57222137-5D2E315D-1618-4497-A791-CEC918275AE9 wds:Q57222137-6DA8C651-2FD7-4D0D-81DF-4796E179B852 wds:Q57222137-736E6518-8B48-4C55-A0BC-F37D4E5D7FA6 wds:Q57222137-7B229385-CF03-44E1-968B-04550C58CDDD wds:Q57222137-83270FB7-5610-411E-BC1B-AFCE2CFFC14B wds:Q57222137-8B2EC4B4-D4C4-43F4-A127-C728C229025D wds:Q57222137-9267B9AB-93E8-49D5-B490-22F588C4823D wds:Q57222137-9DF79F8D-06CD-4DEC-9C0F-0D9C0330DBDA wds:Q57222137-AFD3B2A9-D0CF-47E9-9BE4-381025948D14 wds:Q57222137-B737985C-87D3-4280-BECC-D82945B5BAFF wds:Q57222137-C1564735-DBE6-4398-A8CE-A62117E6EFA5 wds:Q57222137-E0273838-6305-49C9-908D-FA23ABF23C6E wds:Q57222137-F3755ADF-4712-4A4E-95AF-5D301A486254 wds:Q57222137-F453AAA8-B98C-405D-B829-7B245190F8BD wds:Q57222137-FD20B1DC-FB01-4F80-A035-6721D61C07DA wds:Q57222137-FE0113A2-D24E-4169-95A8-AB2216C7FAFE
cites work	Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older Dietary calcium and risk of hip fracture: 14-year prospective population study 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Vitamin D3 and calcium to prevent hip fractures in elderly women Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis Correcting calcium nutritional deficiency prevents spine fractures in elderly women. Understanding and Improving Patient Compliance The effect of prescribed daily dose frequency on patient medication compliance Costs and utilization associated with pharmaceutical adherence in a diabetic population. Bisphosphonates: a review of their pharmacokinetic properties Impact of dosage frequency on patient compliance. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Potential risk factors for development of postmenopausal osteoporosis--examined over a 12-year period Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. The doctor/patient relationship and its effect upon outcome Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance Energy and nutrient intake of young-old, old-old and very-old elderly in Germany The importance of calcium intake for lifelong skeletal health Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60 Self-administration of medicine and older people.
author name string	wds:Q57222137-14ED4EBC-DA10-44EB-A1BC-9303DB594843 wds:Q57222137-806B806B-5722-469B-9794-029AEC523539 wds:Q57222137-CB8FDCDA-8E8A-4958-8E7D-952574C22939
author name string	Gerd Möller Johann D Ringe Stefan A P van der Geest
rdfs:label	Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (en) Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (nl)
skos:prefLabel	Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (en) Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (nl)
name	Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (en) Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (nl)
title	wds:Q57222137-4568264F-B4ED-4857-8540-2C0A14ADF0C8
title	Importance of calcium co-medication in bisphosphonate therapy of osteoporosis: an approach to improving correct intake and drug adherence (en)
page(s)	wds:Q57222137-99CBE963-7871-4270-AB2C-95679CA85A19
page(s)	569-78
instance of	wds:Q57222137-96981E4D-C98A-46A6-A4BD-12F54C7F394B
instance of	scholarly article
main subject	wds:Q57222137-02C439F9-6521-409B-97EB-751DBED16569
main subject	osteoporosis
PubMed ID	wds:Q57222137-6F2085B0-5466-4241-84D3-6D0BFE0CEF7B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16930085
PubMed ID	16930085
published in	wds:Q57222137-0AD77388-E87C-49A6-90B7-986B232ED0CF
published in	Drugs & Aging
issue	wds:Q57222137-F05DF221-7205-47AE-9B1C-B4E3290BD445
volume	wds:Q57222137-50EADEBC-AF93-449E-A167-4915BDBAA37F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software